Subscribe
shutterstock_325058183_crystal51
crystal51 / Shutterstock.com
9 September 2021AsiaKeith Haddaway and Christopher Loh

Amendments to Chinese Patents Law for the Life Sciences

On June 1, 2021, the fourth amendment of the Chinese patent law went into effect. The amendment contains generally applicable provisions and makes specific changes to design patent law and Life Science-related patents.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Chinese state-owned chemical firm in fungicide patent suit
14 November 2019   A Chinese state-owned chemical firm is suing US crop protection products company Atticus for patent infringement.
Americas
FDA to grant licence to Chinese-owned Advion for COVID-19 diagnostic patent
13 November 2020   The US Food and Drug Administration will today announce that it plans to grant a Chinese-owned testing company an exclusive worldwide licence for a US government-owned patent covering a diagnostic test for the rapid detection of COVID-19.
Asia
China accepts cluster of complaints under new patent linkage law
9 November 2021   The China National Intellectual Property Administration has accepted its first set of drug patent linkage complaints since the introduction of a new patent law in June 2021.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024
Americas
Comparing life sciences IP in Brazil and the US
28 November 2024
Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024

More on this story

Americas
Chinese state-owned chemical firm in fungicide patent suit
14 November 2019   A Chinese state-owned chemical firm is suing US crop protection products company Atticus for patent infringement.
Americas
FDA to grant licence to Chinese-owned Advion for COVID-19 diagnostic patent
13 November 2020   The US Food and Drug Administration will today announce that it plans to grant a Chinese-owned testing company an exclusive worldwide licence for a US government-owned patent covering a diagnostic test for the rapid detection of COVID-19.
Asia
China accepts cluster of complaints under new patent linkage law
9 November 2021   The China National Intellectual Property Administration has accepted its first set of drug patent linkage complaints since the introduction of a new patent law in June 2021.

More on this story

Americas
Chinese state-owned chemical firm in fungicide patent suit
14 November 2019   A Chinese state-owned chemical firm is suing US crop protection products company Atticus for patent infringement.
Americas
FDA to grant licence to Chinese-owned Advion for COVID-19 diagnostic patent
13 November 2020   The US Food and Drug Administration will today announce that it plans to grant a Chinese-owned testing company an exclusive worldwide licence for a US government-owned patent covering a diagnostic test for the rapid detection of COVID-19.
Asia
China accepts cluster of complaints under new patent linkage law
9 November 2021   The China National Intellectual Property Administration has accepted its first set of drug patent linkage complaints since the introduction of a new patent law in June 2021.

More features

Sarepta wins $115M in patent dispute over muscular dystrophy drug
Novartis shields eye-drop patent at European Patent Office
CREATES Act unfairly tips the scales to generics
LSPN launches its first-ever US awards to celebrate life sciences leaders
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York
‘A marathon and a sprint at the same time’: How we won $452m damages
Judge denies Intellia bid to throw out suit over $100m Regeneron pact